BivalirudineGACON, Pierre-Henry.Archives des maladies du coeur et des vaisseaux. Pratique. 2005, Num 142, pp 38-39, issn 1261-694X, 2 p.Article

Brachytherapy and bivalirudin evaluation studyKUCHULAKANTI, Pramod; WOLFRAM, Roswitha; WAKSMAN, Ron et al.The American heart journal. 2005, Vol 150, Num 4, pp 832-837, issn 0002-8703, 6 p.Article

Validation of the i-STAT handheld activated clotting time for use with BivalirudinSCHUSSLER, Jeffrey M; LANDER, Stuart R; WISSINGER, Laurie A et al.The American journal of cardiology. 2004, Vol 93, Num 10, pp 1318-1319, issn 0002-9149, 2 p.Article

A 24-hour continuous infusion study of bivalirudin in the ratGLEASON, Teresa G; CHENGELIS, Christopher P; JACKSON, Carney B et al.International journal of toxicology. 2003, Vol 22, Num 3, pp 195-206, issn 1091-5818, 12 p.Article

Bivalirudin : Current use of biologicals in thrombosis and haemostasisWARKENTIN, Theodore E; GREINACHER, Andreas; KOSTER, Andreas et al.Thrombosis and haemostasis. 2008, Vol 99, Num 5, pp 830-839, issn 0340-6245, 10 p.Article

Heparin versus bivalirudin for carotid artery stenting using proximal endovascular clamping for neuroprotection: Results from a prospective randomized studySTABILE, Eugenio; SORROPAGO, Giovanni; TESORIO, Tullio et al.Journal of vascular surgery. 2010, Vol 52, Num 6, pp 1505-1510, issn 0741-5214, 6 p.Article

Impact of smart infusion technology on administration of anticoagulants (Unfractionated heparin, Argatroban, Lepirudin, and Bivalirudin)FANIKOS, John; FIUMARA, Karen; BAROLETTI, Steve et al.The American journal of cardiology. 2007, Vol 99, Num 7, pp 1002-1005, issn 0002-9149, 4 p.Article

Effectiveness and safety of bivalirudin during percutaneous coronary intervention in a single medical centerGURM, Hitinder S; RAJAGOPAL, Vivek; FATHI, Robert et al.The American journal of cardiology. 2005, Vol 95, Num 6, pp 716-721, issn 0002-9149, 6 p.Article

Value of monitoring activated clotting time when bivalirudin is used as the sole anticoagulation agent for percutaneous coronary interventionCHENEAU, Edouard; CANOS, Daniel; KUCHULAKANTI, Pramod K et al.The American journal of cardiology. 2004, Vol 94, Num 6, pp 789-792, issn 0002-9149, 4 p.Article

Regulation of PAR-1 in patients undergoing percutaneous coronary intervention: effect of unfractionated heparin and bivalirudinBADR ESTAM, Roza; REITER, Nina; KAIDER, Alexandra et al.European heart journal. 2009, Vol 30, Num 15, pp 1831-1836, issn 0195-668X, 6 p.Article

Bivalirudin Inhibits Periprocedural Platelet Function and Tissue Factor Expression of Human Smooth Muscle CellsPEPKE, Wojciech; EISENREICH, Andreas; JASTER, Markus et al.Cardiovascular therapeutics (Print). 2013, Vol 31, Num 2, pp 115-123, issn 1755-5914, 9 p.Article

Les inhibiteurs directs de la thrombine, l'hirudine, la bivalirudine, l'argatroban, et le dabigatran etexilate = Direct inhibitors of thrombin, hirudin, bivalirudin, and dabigatran etexilateMEDDAHI, S; SAMAMA, M. M.Journal des maladies vasculaires. 2011, Vol 36, Num 1, pp 24-32, issn 0398-0499, 9 p.Article

Profile of bleeding and ischaemic complications with bivalirudin and unfractionated heparin after percutaneous coronary interventionIIJIMA, Raisuke; NDREPEPA, Gjin; MEHILLI, Julinda et al.European heart journal. 2009, Vol 30, Num 3, pp 290-296, issn 0195-668X, 7 p.Article

Bivalirudin for Patients with Heparin-lnduced Thrombocytopenia Undergoing Cardiovascular SurgeryCZOSNOWSKI, Quinn A; FINKS, Shannon W; ROGERS, Kelly C et al.The Annals of pharmacotherapy. 2008, Vol 42, Num 9, pp 1304-1309, issn 1060-0280, 6 p.Article

The Anti-Inflammatory Effects of Argatroban Can Be Differentiated from Other Direct Thrombin Inhibitors : Experimental and Clinical ObservationsHOPPENSTEADT, Debra A; JESKE, Walter; WALENGA, Jeanine M et al.Seminars in thrombosis and hemostasis. 2008, Vol 34, pp 97-102, issn 0094-6176, 6 p., SUP1Article

Successful Use and Dosing of Bivalirudin After Temporary Total Artificial Heart Implantation : A Case SeriesCROUCH, Michael A; KASIRAJAN, Vigeshwar; CAHOON, William et al.Pharmacotherapy. 2008, Vol 28, Num 11, pp 1413-1420, issn 0277-0008, 8 p.Article

Influence of bivalirudin on tissue factor-triggered coagulationBUTENAS, Saulius; ORFEO, Thomas; BRUMMEL-ZIEDINS, Kathleen E et al.Blood coagulation & fibrinolysis. 2007, Vol 18, Num 5, pp 407-414, issn 0957-5235, 8 p.Article

Treatment of heparin-induced thrombocytopenia : Is there a role for bivalirudin?SEYBERT, Amy L; COONS, James C; ZERUMSKY, Kristin et al.Pharmacotherapy. 2006, Vol 26, Num 2, pp 229-241, issn 0277-0008, 13 p.Article

ISAR-REACT 3A: a study of reduced dose of unfractionated heparin in biomarker negative patients undergoing percutaneous coronary interventionSCHULZ, Stefanie; MEHILLI, Julinda; NDREPEPA, Gjin et al.European heart journal. 2010, Vol 31, Num 20, pp 2482-2491, issn 0195-668X, 10 p.Article

Validation of Long-Term Benefits of Bivalirudin Versus Unfractionated Heparin in Routine Clinical Practice After Percutaneous Coronary InterventionVIDI, Venkatesan D; MATHENY, Michael E; AGARWAL, Vikram et al.The American journal of cardiology. 2010, Vol 106, Num 9, pp 1234-1240, issn 0002-9149, 7 p.Article

Assessment of hemostatic activation during cardiopulmonary bypass for coronary artery bypass grafting with bivalirudin : Results of a pilot studyKOSTER, Andreas; YETER, Ruhi; BUZ, Semih et al.Journal of thoracic and cardiovascular surgery. 2005, Vol 129, Num 6, pp 1391-1394, issn 0022-5223, 4 p.Article

Comparison of Bivalirudin versus heparin during percutaneous coronary intervention (the randomized evaluation of pcl linking angiomax to reduced clinical events [REPLACE]-1 Trial)LINCOFF, A. Michael; BITTL, John A; PARKER, H. Graham et al.The American journal of cardiology. 2004, Vol 93, Num 9, pp 1092-1096, issn 0002-9149, 5 p.Article

An assessment of different filter systems for extracorporeal elimination of bivalirudin: An in vitro studyKOSTER, Andreas; CHEW, Derek; GRÜNDEL, Marcus et al.Anesthesia and analgesia. 2003, Vol 96, Num 5, pp 1316-1319, issn 0003-2999, 4 p.Article

Anticoagulation in acute cardiac care in patients with chronic kidney diseaseREDDAN, Donal; SZCZECH, Lynda A; O'SHEA, Susan et al.The American heart journal. 2003, Vol 145, Num 4, pp 586-594, issn 0002-8703, 9 p.Article

Effect of direct thrombin inhibition with Bivalirudin (hirulog) on restenosis after coronary angioplastyBURCHENAL, J. E. B; MARKS, D. S; MANN, J. T et al.The American journal of cardiology. 1998, Vol 82, Num 4, pp 511-515, issn 0002-9149Article